When to switch biologics: some answers, but lots of questions too
- PMID: 29357593
- DOI: 10.1111/bjd.16118
When to switch biologics: some answers, but lots of questions too
Comment on
-
Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial.Br J Dermatol. 2018 Jan;178(1):114-123. doi: 10.1111/bjd.15750. Epub 2017 Oct 10. Br J Dermatol. 2018. PMID: 28635018 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources